Cargando…
Is Inhaled Furosemide a Potential Therapeutic for COVID-19?
The potentially lethal infection caused by the novel Severe Acute Respiratory Disease Coronavirus-2 (SARS-CoV-2) has evolved into a global crisis. Following the initial viral infection is the host inflammatory response that frequently results in excessive secretion of inflammatory cytokines (e.g., I...
Autores principales: | Brennecke, Anja, Villar, Laura, Wang, Zhiyu, Doyle, Lisa M., Meek, Autumn, Reed, Mark, Barden, Christopher, Weaver, Donald F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Southern Society for Clinical Investigation. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833957/ https://www.ncbi.nlm.nih.gov/pubmed/32622469 http://dx.doi.org/10.1016/j.amjms.2020.05.044 |
Ejemplares similares
-
Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide
por: Wang, Zhiyu, et al.
Publicado: (2020) -
Indoleamine 2,3-Dioxygenase as a Therapeutic Target for Alzheimer’s Disease and Geriatric Depression
por: Savonije, Karl, et al.
Publicado: (2023) -
Effectiveness of inhaled furosemide for acute asthma exacerbation: a meta-analysis
por: Inokuchi, Ryota, et al.
Publicado: (2014) -
Effects of inhaled furosemide on dyspnea and pulmonary function in people with COPD: A literature review
por: Atwi, Zeina
Publicado: (2022) -
Inhaled furosemide for relief of air hunger versus sense of breathing effort: a randomized controlled trial
por: Grogono, Joanna C., et al.
Publicado: (2018)